VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q55965677 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000143.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q55965677‏
024 ‎‡a 0000-0001-6877-5345‏ ‎‡2 orcid‏
024 ‎‡a 56072243700‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q55965677‏
100 0 ‎‡a Kuan-Yin Lin‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
400 0 ‎‡a Kuan-Yin Lin‏ ‎‡c researcher ORCID: 0000-0001-6877-5345‏ ‎‡9 en‏
400 0 ‎‡a Kuan-Yin Lin‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey‏
670 ‎‡a Author's Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections‏
670 ‎‡a Author's Central line-associated bloodstream infections among critically-ill patients in the era of bundle care‏
670 ‎‡a Author's Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy‏
670 ‎‡a Author's Clinical relevance of cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.‏
670 ‎‡a Author's Comparable serologic responses to 2 different combinations of inactivated HAV vaccines in HIV-positive patients during the acute hepatitis A outbreak in Taiwan.‏
670 ‎‡a Author's Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Patients: Incidence and Associated Factors‏
670 ‎‡a Author's Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: A time-dependent analysis‏
670 ‎‡a Author's Enterobius vermicularis infection mimicking strongyloidiasis: A case report‏
670 ‎‡a Author's Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan‏
670 ‎‡a Author's Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study‏
670 ‎‡a Author's Hepatitis A Outbreak Among Men Who Have Sex With Men in a Country of Low Endemicity of Hepatitis A Infection‏
670 ‎‡a Author's Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review‏
670 ‎‡a Author's Hepatitis E Virus Infections Among Human Immunodeficiency Virus-Positive Individuals During an Outbreak of Acute Hepatitis A in Taiwan‏
670 ‎‡a Author's Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection‏
670 ‎‡a Author's Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination‏
670 ‎‡a Author's Serologic Responses and Effectiveness of Hepatitis A Vaccination Among HIV-Positive Individuals During the Outbreak of Acute Hepatitis A.‏
670 ‎‡a Author's Serological responses to revaccination against HBV in HIV-positive patients born in the era of nationwide neonatal HBV vaccination.‏
670 ‎‡a Author's Serological responses to revaccination with hepatitis A virus‏
670 ‎‡a Author's Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination.‏
670 ‎‡a Author's Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: incidence and associated factor.‏
670 ‎‡a Author's Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up‏
909 ‎‡a (scopus) 56072243700‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000168775345‏ ‎‡9 1‏
919 ‎‡a trendsandoutcomesoflateinitiationofcombinationantiretroviraltherapydrivenbylatepresentationamonghivpositivetaiwanesepatientsintheeraoftreatmentscaleup‏ ‎‡A Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up‏ ‎‡9 1‏
919 ‎‡a serologicalresponsestorevaccinationwithhepatitisavirus‏ ‎‡A Serological responses to revaccination with hepatitis A virus‏ ‎‡9 1‏
919 ‎‡a serologicalresponsestorevaccinationagainsthbvinhivpositivepatientsbornintheeraofnationwideneonatalhbvvaccination‏ ‎‡A Serological responses to revaccination against HBV in HIV-positive patients born in the era of nationwide neonatal HBV vaccination.‏ ‎‡9 1‏
919 ‎‡a serologicresponsesandeffectivenessofhepatitisavaccinationamonghivpositiveindividualsduringtheoutbreakofacutehepatitisa‏ ‎‡A Serologic Responses and Effectiveness of Hepatitis A Vaccination Among HIV-Positive Individuals During the Outbreak of Acute Hepatitis A.‏ ‎‡9 1‏
919 ‎‡a incidenceofacutehepatitisaamonghivpositivepatientsduringanoutbreakamongmsmintaiwanimpactofhavvaccination‏ ‎‡A Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination‏ ‎‡9 1‏
919 ‎‡a impactofantiretroviraltherapycontainingtenofovirdisoproxilfumarateonthesurvivalofpatientswithhbvandhivcoinfection‏ ‎‡A Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection‏ ‎‡9 1‏
919 ‎‡a hepatitisevirusinfectionsamonghumanimmunodeficiencyviruspositiveindividualsduringanoutbreakofacutehepatitisaintaiwan‏ ‎‡A Hepatitis E Virus Infections Among Human Immunodeficiency Virus-Positive Individuals During an Outbreak of Acute Hepatitis A in Taiwan‏ ‎‡9 1‏
919 ‎‡a hepatitisavirusinfectionandhepatitisavaccinationinhumanimmunodeficiencyviruspositivepatientsareview‏ ‎‡A Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review‏ ‎‡9 1‏
919 ‎‡a hepatitisaoutbreakamongmenwhohavesexwithmeninacountryoflowendemicityofhepatitisainfection‏ ‎‡A Hepatitis A Outbreak Among Men Who Have Sex With Men in a Country of Low Endemicity of Hepatitis A Infection‏ ‎‡9 1‏
919 ‎‡a fluoroquinolonesversusβlactamβlactamaseinhibitorsinoutpatientswithchronicobstructivepulmonarydiseaseandpneumoniaanationwidepopulationbasedstudy‏ ‎‡A Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study‏ ‎‡9 1‏
919 ‎‡a evolutionofhepatitisavirusseroprevalenceamonghivpositiveadultsintaiwan‏ ‎‡A Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan‏ ‎‡9 1‏
919 ‎‡a enterobiusvermicularisinfectionmimickingstrongyloidiasisacasereport‏ ‎‡A Enterobius vermicularis infection mimicking strongyloidiasis: A case report‏ ‎‡9 1‏
919 ‎‡a effectivenessofechinocandinsversusfluconazolefortreatmentofpersistentcandidemiaatimedependentanalysis‏ ‎‡A Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: A time-dependent analysis‏ ‎‡9 1‏
919 ‎‡a earlyseroreversionafter2dosesofhepatitisavaccinationinhumanimmunodeficiencyviruspositivepatientsincidenceandassociatedfactors‏ ‎‡A Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Patients: Incidence and Associated Factors‏ ‎‡9 1‏
919 ‎‡a comparableserologicresponsesto2differentcombinationsofinactivatedhavvaccinesinhivpositivepatientsduringtheacutehepatitisaoutbreakintaiwan‏ ‎‡A Comparable serologic responses to 2 different combinations of inactivated HAV vaccines in HIV-positive patients during the acute hepatitis A outbreak in Taiwan.‏ ‎‡9 1‏
919 ‎‡a clinicalrelevanceofcrossreactivitybetweendarunavirandtrimethoprimsulfamethoxazoleinhivinfectedpatients‏ ‎‡A Clinical relevance of cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.‏ ‎‡9 1‏
919 ‎‡a cholelithiasisandnephrolithiasisinhivpositivepatientsintheeraofcombinationantiretroviraltherapy‏ ‎‡A Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy‏ ‎‡9 1‏
919 ‎‡a centrallineassociatedbloodstreaminfectionsamongcriticallyillpatientsintheeraofbundlecare‏ ‎‡A Central line-associated bloodstream infections among critically-ill patients in the era of bundle care‏ ‎‡9 1‏
919 ‎‡a carbapenemresistantpseudomonasaeruginosaintaiwanprevalenceriskfactorsandimpactonoutcomeofinfections‏ ‎‡A Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections‏ ‎‡9 1‏
919 ‎‡a awarenessandwillingnesstowardspreexposureprophylaxisagainsthivinfectionamongindividualsseekingvoluntarycounsellingandtestingforhivintaiwanacrosssectionalquestionnairesurvey‏ ‎‡A Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey‏ ‎‡9 1‏
919 ‎‡a serologicalresponsestorevaccinationwithhepatitisavirushavvaccinesamonghivpositiveindividualswhoseantihavantibodywanedafterprimaryvaccination‏ ‎‡A Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination.‏ ‎‡9 1‏
919 ‎‡a skinrashrelatedto11dailyboosteddarunavircontainingantiretroviraltherapyinhivinfectedtaiwaneseincidenceandassociatedfactor‏ ‎‡A Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: incidence and associated factor.‏ ‎‡9 1‏
996 ‎‡2 NII|DA03137500‏
996 ‎‡2 DNB|1089617917‏
996 ‎‡2 CYT|AC000657498‏
996 ‎‡2 LC|no 96053673‏
996 ‎‡2 SUDOC|095617825‏
996 ‎‡2 CYT|AC000636826‏
996 ‎‡2 PLWABN|9812479958105606‏
996 ‎‡2 CYT|AC000662877‏
996 ‎‡2 NLA|000035056720‏
996 ‎‡2 ISNI|0000000431168834‏
996 ‎‡2 DNB|1301481769‏
996 ‎‡2 CYT|AC000654844‏
996 ‎‡2 LC|no2015139272‏
996 ‎‡2 LC|n 2010021760‏
996 ‎‡2 ISNI|0000000063531950‏
996 ‎‡2 CYT|AC000636830‏
996 ‎‡2 ISNI|0000000064042980‏
996 ‎‡2 LC|n 85362254‏
996 ‎‡2 ISNI|0000000064051844‏
996 ‎‡2 LC|n 82234663‏
996 ‎‡2 CYT|AC000524855‏
996 ‎‡2 CYT|AC000658553‏
996 ‎‡2 CYT|AC000618146‏
996 ‎‡2 SUDOC|133625850‏
996 ‎‡2 DNB|1298979048‏
996 ‎‡2 CYT|AC000640541‏
996 ‎‡2 LC|no2022145540‏
996 ‎‡2 CYT|AC000644456‏
996 ‎‡2 LC|n 81141304‏
996 ‎‡2 CYT|AC000008192‏
996 ‎‡2 LC|n 2012031980‏
996 ‎‡2 ISNI|0000000119426712‏
996 ‎‡2 CYT|AC000569597‏
996 ‎‡2 CYT|AC000644362‏
996 ‎‡2 CYT|AC000644500‏
996 ‎‡2 ISNI|000000007811384X‏
996 ‎‡2 NSK|000739519‏
996 ‎‡2 ISNI|0000000063505058‏
996 ‎‡2 ISNI|0000000063736390‏
996 ‎‡2 DNB|1123103615‏
996 ‎‡2 ISNI|0000000063673924‏
996 ‎‡2 CYT|AC000652629‏
996 ‎‡2 CYT|AC000636790‏
996 ‎‡2 LC|n 88137445‏
996 ‎‡2 LC|no 88001452‏
996 ‎‡2 BIBSYS|90174312‏
996 ‎‡2 CYT|AC000590425‏
996 ‎‡2 ISNI|0000000084179028‏
996 ‎‡2 DE633|pe40212329‏
996 ‎‡2 ISNI|0000000064263556‏
996 ‎‡2 ISNI|0000000082559158‏
996 ‎‡2 CYT|AC000579782‏
996 ‎‡2 CYT|AC000644873‏
996 ‎‡2 CYT|AC000657817‏
996 ‎‡2 LC|n 86022939‏
996 ‎‡2 NTA|141295007‏
996 ‎‡2 ISNI|0000000063617041‏
996 ‎‡2 DNB|1163324515‏
996 ‎‡2 CYT|AC000580382‏
996 ‎‡2 CYT|AC000655530‏
996 ‎‡2 CYT|AC000652887‏
996 ‎‡2 CYT|AC000657913‏
996 ‎‡2 CYT|AC000659447‏
996 ‎‡2 ISNI|0000000383612311‏
996 ‎‡2 CYT|AC000637032‏
996 ‎‡2 CYT|AC000662860‏
996 ‎‡2 CYT|AC000639653‏
996 ‎‡2 CYT|AC000653986‏
996 ‎‡2 SUDOC|277090482‏
996 ‎‡2 NUKAT|n 2021211158‏
996 ‎‡2 CYT|AC000634017‏
996 ‎‡2 CYT|AC000220437‏
996 ‎‡2 CYT|AC000220436‏
996 ‎‡2 J9U|987007439708305171‏
996 ‎‡2 CYT|AC000220432‏
996 ‎‡2 CYT|AC000220430‏
996 ‎‡2 PLWABN|9813200046705606‏
996 ‎‡2 CYT|AC000579902‏
996 ‎‡2 CYT|AC000644404‏
996 ‎‡2 BNF|16509164‏
996 ‎‡2 CYT|AC000089578‏
996 ‎‡2 ISNI|0000000456766750‏
996 ‎‡2 PLWABN|9810563406805606‏
996 ‎‡2 CYT|AC000639403‏
996 ‎‡2 ISNI|0000000063568462‏
996 ‎‡2 CYT|AC000220424‏
996 ‎‡2 CYT|AC000220425‏
996 ‎‡2 CYT|AC000220427‏
996 ‎‡2 CYT|AC000661118‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏